Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
International Journal of Cancer, 05/02/2012
Reifenberger G et al. – O6–methylguanine–DNA–methyltransferase (MGMT) promoter methylation may be a useful biomarker to stratify elderly glioblastoma patients for treatment with versus without alkylating agent chemotherapy (CT).



